US removes WuXi AppTec from Chinese military blacklist, easing pharma supply fears

The Trump administration has delisted WuXi AppTec from its Chinese military companies list, reversing a prior designation that threatened the pharma supply chain. This signals a softening of US-China trade tensions in the biotech sector, though the move's permanence and broader policy implications remain uncertain. The delisting reduces immediate risk of supply disruption for drugmakers reliant on WuXi's services.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works